Skip to main content
. Author manuscript; available in PMC: 2022 Sep 17.
Published in final edited form as: Ophthalmology. 2017 Jun 16;124(8):1099–1107. doi: 10.1016/j.ophtha.2017.04.034

Table 1.

Topical Antibiotic Classes

Antibiotic Number and % of patients*

Fluoroquinolones 65994 (33%)
 Besifloxacin
 Ciprofloxacin
 Gatifloxacin
 Levofloxacin
 Moxifloxacin
 Ofloxacin

Aminoglycosides 22651 (11%)
 Gentamycin
 Tobramycin

Polymyxins 31070 (16%)
 Polymyxin/Bacitracin
 Polymycin/Bacitracin/Neomycin
 Polymyxin/Neomycin/Gramicidin
 Polymyxin/Trimethoprim

Sulfonamides 14463 (7%)
 Sulfacetamide

Macrolides 34815 (18%)
 Erythromycin
 Azithromycin

Bacitracin 606 (0.3%)
 Bacitracin

Antibiotic-corticosteroid combinations 38774 (20%)
 Polymycin/Neomycin/Bacitracin/Hydrocortisone
 Polymyxin/Neomycin/Dexamethasone
 Polymyxin/Neomycin/Hydrocortisone
 Sulfacetamide/Prednisolone
 Tobramycin/Dexamethasone
 Tobramycin/Loprednol
*

Percentage of patients with newly diagnosed acute conjunctivitis who filled >1 prescriptions for topical antibiotics belonging to each antibiotic category within 14 days of initial diagnosis. Some patients may have filled prescriptions for more than one agent in a given class or agents from more than 1 class during the 14 day period so the total number of prescriptions filled does not equal the total number of patients who filled prescriptions.